Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial

Background and Purpose Moderate-intensity statin plus ezetimibe versus high-intensity statin alone may provide a greater low-density lipoprotein cholesterol (LDL-C) reduction in patients with recent ischemic stroke. Methods This randomized, open-label, controlled trial assigned patients with recent...

Полное описание

Библиографические подробности

Главные авторы:	Keun-Sik Hong, Oh Young Bang, Jong-Ho Park, Jin-Man Jung, Sang-Hun Lee, Tae-Jin Song, Hyo Suk Nam, Hee-Kwon Park, Keun-Hwa Jung, Sung Hyuk Heo, Jaseong Koo, Kyung-Ho Yu, Kwang-Yeol Park, Chi Kyung Kim, Hong-Kyun Park, Jiyoon Lee, Juneyoung Lee, Woo-Keun Seo
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Korean Stroke Society 2023-05-01
Серии:	Journal of Stroke
Предметы:	stroke ldl cholesterol rosuvastatin ezetimibe target goal
Online-ссылка:	http://www.j-stroke.org/upload/pdf/jos-2022-02957.pdf
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!